세계의 말초 혈관 스텐트 임플란트 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral stent implants. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Peripheral Stent Implants Market Size (2024E): USD 4.1 Bn
• Projected Market Value (2033F): USD 7.5 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 6.9%

Peripheral Stent Implants Market - Report Scope:

Peripheral stent implants are vital medical devices used to open narrowed or blocked arteries in the peripheral vascular system, including the legs, arms, and other areas outside the heart. These stents help restore proper blood flow, preventing severe complications like limb ischemia. The market for peripheral stent implants is driven by the growing prevalence of peripheral artery disease (PAD), advancements in stent technology, and increasing demand for minimally invasive procedures. The report provides insights into various types of stents, such as bare-metal stents, drug-eluting stents, and bioresorbable stents, and their applications across different patient demographics.

Market Growth Drivers:

The global peripheral stent implants market is propelled by several key factors, including the rising incidence of PAD due to an aging population, diabetes, and lifestyle-related risk factors. Technological advancements, such as the development of drug-eluting stents and bioresorbable scaffolds, are enhancing treatment outcomes and driving market growth. Additionally, the shift towards minimally invasive procedures, which offer shorter recovery times and lower complication rates, is increasing the adoption of stent implants. Government initiatives and healthcare policies aimed at improving vascular health also contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the peripheral stent implants market faces challenges related to high costs and reimbursement issues. The advanced technology used in modern stents often leads to higher prices, which can be a barrier for patients and healthcare providers, especially in emerging economies. Additionally, complications such as restenosis and stent thrombosis pose clinical challenges, potentially limiting market growth. Regulatory hurdles and the need for long-term clinical data to support new product approvals also present challenges for market players.

Market Opportunities:

The peripheral stent implants market presents significant growth opportunities driven by ongoing research and development, increasing awareness of vascular diseases, and expanding healthcare infrastructure in emerging markets. The development of next-generation stents with improved biocompatibility, flexibility, and drug-delivery capabilities offers potential for enhanced treatment outcomes. Market players can capitalize on these opportunities by investing in innovation, forming strategic partnerships with healthcare providers, and focusing on patient-centric product development. The growing trend towards personalized medicine and the adoption of advanced imaging technologies also create avenues for market growth.

• Key Questions Answered in the Report:
• What are the primary factors driving the growth of the peripheral stent implants market globally?
• Which types of stents and technologies are leading adoption across different patient demographics?
• How are technological advancements influencing the competitive landscape of the peripheral stent implants market?
• Who are the key players contributing to the peripheral stent implants market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global peripheral stent implants market?

Competitive Intelligence and Business Strategy:

Leading players in the global peripheral stent implants market, including Boston Scientific Corporation, Abbott Laboratories, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced stent solutions, including drug-eluting stents and bioresorbable scaffolds, catering to diverse clinical needs and regulatory standards. Collaborations with healthcare providers, research institutions, and regulatory bodies facilitate market access and promote technology adoption. Emphasis on clinical outcomes, patient safety, and cost-effectiveness drives market growth and reinforces the position of key players in the evolving vascular treatment landscape.

Key Companies Profiled:

• Abbott Laboratories
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Medical, Inc.
• Cardinal Health, Inc.
• iVascular SLU
• Medtronic Plc.
• Terumo Corporation
• W. L. Gore & Associates Inc.

Key Segments Covered in Peripheral Stent Implants Industry Research

Product

• Bare Metal Stents (BMS)
• Covered Stents
• Drug Eluting Stents (DES)

Artery

• Carotid Artery Stents
• Fem-Pop Artery Stents
• Iliac Artery Stents
• Infrapop Artery Stents

End User

• Hospitals
• Ambulatory Surgical Centers/Outpatient

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Market Innovation / Development Trends

4. Key Success Factors

• 4.1. Key Promotional Strategies, by Manufacturers
• 4.2. Key Regulations
• 4.3. PESTEL Analysis
• 4.4. Porter's Analysis
• 4.5. Product Launch Activities
• 4.6. Product Adoption/Usage Analysis
• 4.7. Reimbursement
• 4.8. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Peripheral Vascular Devices Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. New Product Launches and Approvals
  • 5.2.3. Global Peripheral Vascular Diseases
  • 5.2.4. Research and Development Expenditure by Key Players
  • 5.2.5. Historic and Current Revenue of Key Players
  • 5.2.6. Rising Consumer Awareness of the Product
  • 5.2.7. Rising Adoption of Device Technological Development
  • 5.2.8. Strategic Developments by Key Players
  • 5.2.9. Increasing Adoption of Peripheral Vascular Devices for Various Arteries
  • 5.2.10. Strategic Collaborations among Players
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Artery
  • 6.1.3. By End User
  • 6.1.4. By Country
• 6.2. 2024 Market Scenario

7. Global Market Volume ('000 Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
• 7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Material
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Bn) and Volume ('000 Units) Analysis, 2019-2023
• 9.2. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis by Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Product, 2024-2033
  • 10.3.1. Bare Metal Stents (BMS)
  • 10.3.2. Covered Stents
  • 10.3.3. Drug Eluting Stents (DES)
• 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis by Artery, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Artery, 2024-2033
  • 11.3.1. Carotid Artery Stents
  • 11.3.2. Fem-Pop Artery Stents
  • 11.3.3. Iliac Artery Stents
  • 11.3.4. Infrapop Artery Stents
• 11.4. Market Attractiveness Analysis by Artery

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2033
  • 12.3.1. Hospitals
  • 12.3.2. Ambulatory Surgical Centers/Outpatients
• 12.4. Market Attractiveness Analysis by End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 13.1. Introduction / Key Findings
• 13.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis, by Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis Forecast by Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East & Africa
• 13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By Artery
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Artery
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. U.S. Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Artery
      • 14.8.1.2.3. By End User
  • 14.8.2. Canada Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Artery
      • 14.8.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Mexico
    • 15.3.1.2. Brazil
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product
  • 15.3.3. By Artery
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Artery
  • 15.4.4. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Mexico Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Artery
      • 15.8.1.2.3. By End User
  • 15.8.2. Brazil Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Artery
      • 15.8.2.2.3. By End User
  • 15.8.3. Argentina Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Artery
      • 15.8.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Russia
    • 16.3.1.8. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By Artery
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Artery
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Germany Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Artery
      • 16.8.1.2.3. By End User
  • 16.8.2. Italy Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Artery
      • 16.8.2.2.3. By End User
  • 16.8.3. France Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Artery
      • 16.8.3.2.3. By End User
  • 16.8.4. U.K. Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Artery
      • 16.8.4.2.3. By End User
  • 16.8.5. Spain Market Analysis
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By Artery
      • 16.8.5.2.3. By End User
  • 16.8.6. BENELUX Market Analysis
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By Artery
      • 16.8.6.2.3. By End User
  • 16.8.7. Russia Market Analysis
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By Artery
      • 16.8.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By Artery
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Artery
  • 17.4.4. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. China Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Artery
      • 17.8.1.2.3. By End User
  • 17.8.2. Japan Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Artery
      • 17.8.2.2.3. By End User
  • 17.8.3. South Korea Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Artery
      • 17.8.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. India
    • 18.3.1.2. Indonesia
    • 18.3.1.3. Malaysia
    • 18.3.1.4. Thailand
    • 18.3.1.5. Rest of South Asia
  • 18.3.2. By Product
  • 18.3.3. By Artery
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Artery
  • 18.4.4. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. India Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Artery
      • 18.8.1.2.3. By End User
  • 18.8.2. Indonesia Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Artery
      • 18.8.2.2.3. By End User
  • 18.8.3. Malaysia Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Artery
      • 18.8.3.2.3. By End User
  • 18.8.4. Thailand Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Artery
      • 18.8.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By Artery
  • 19.3.4. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Artery
  • 19.4.4. By End User
• 19.5. Market Trends
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. Australia Market Analysis
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By Artery
      • 19.8.1.2.3. By End User
  • 19.8.2. New Zealand Market Analysis
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By Artery
      • 19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkiye
    • 20.3.1.3. North Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By Artery
  • 20.3.4. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Artery
  • 20.4.4. By End User
• 20.5. Market Trends
• 20.6. Key Market Participants - Intensity Mapping
• 20.7. Drivers and Restraints - Impact Analysis
• 20.8. Country Level Analysis & Forecast
  • 20.8.1. GCC Countries Market Analysis
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By Artery
      • 20.8.1.2.3. By End User
    • 20.8.1.3. Turkiye Market Analysis
    • 20.8.1.4. Introduction
    • 20.8.1.5. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.5.1. By Product
      • 20.8.1.5.2. By Artery
      • 20.8.1.5.3. By End User
  • 20.8.2. South Africa Market Analysis
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By Artery
      • 20.8.2.2.3. By End User
  • 20.8.3. North Africa Market Analysis
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By Artery
      • 20.8.3.2.3. By End User

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Abbott Laboratories
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Sales Footprint
    • 22.3.1.4. Key Financials
    • 22.3.1.5. SWOT Analysis
    • 22.3.1.6. Key Developments
    • 22.3.1.7. Strategy Overview
      • 22.3.1.7.1. Marketing Strategy
      • 22.3.1.7.2. Product Strategy
      • 22.3.1.7.3. Channel Strategy
  • 22.3.2. B. Braun Melsungen AG
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Sales Footprint
    • 22.3.2.4. Key Financials
    • 22.3.2.5. SWOT Analysis
    • 22.3.2.6. Key Developments
    • 22.3.2.7. Strategy Overview
      • 22.3.2.7.1. Marketing Strategy
      • 22.3.2.7.2. Product Strategy
      • 22.3.2.7.3. Channel Strategy
  • 22.3.3. Biotronik SE & Co. KG
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Sales Footprint
    • 22.3.3.4. Key Financials
    • 22.3.3.5. SWOT Analysis
    • 22.3.3.6. Key Developments
    • 22.3.3.7. Strategy Overview
      • 22.3.3.7.1. Marketing Strategy
      • 22.3.3.7.2. Product Strategy
      • 22.3.3.7.3. Channel Strategy
  • 22.3.4. Boston Scientific Corporation
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Sales Footprint
    • 22.3.4.4. Key Financials
    • 22.3.4.5. SWOT Analysis
    • 22.3.4.6. Key Developments
    • 22.3.4.7. Strategy Overview
      • 22.3.4.7.1. Marketing Strategy
      • 22.3.4.7.2. Product Strategy
      • 22.3.4.7.3. Channel Strategy
  • 22.3.5. Cook Medical, Inc.
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Sales Footprint
    • 22.3.5.4. Key Financials
    • 22.3.5.5. SWOT Analysis
    • 22.3.5.6. Key Developments
    • 22.3.5.7. Strategy Overview
      • 22.3.5.7.1. Marketing Strategy
      • 22.3.5.7.2. Product Strategy
      • 22.3.5.7.3. Channel Strategy
  • 22.3.6. Cardinal Health, Inc.
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Sales Footprint
    • 22.3.6.4. Key Financials
    • 22.3.6.5. SWOT Analysis
    • 22.3.6.6. Key Developments
    • 22.3.6.7. Strategy Overview
      • 22.3.6.7.1. Marketing Strategy
      • 22.3.6.7.2. Product Strategy
      • 22.3.6.7.3. Channel Strategy
  • 22.3.7. iVascular SLU
    • 22.3.7.1. Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Sales Footprint
    • 22.3.7.4. Key Financials
    • 22.3.7.5. SWOT Analysis
    • 22.3.7.6. Key Developments
    • 22.3.7.7. Strategy Overview
      • 22.3.7.7.1. Marketing Strategy
      • 22.3.7.7.2. Product Strategy
      • 22.3.7.7.3. Channel Strategy
  • 22.3.8. Medtronic Plc.
    • 22.3.8.1. Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Sales Footprint
    • 22.3.8.4. Key Financials
    • 22.3.8.5. SWOT Analysis
    • 22.3.8.6. Key Developments
    • 22.3.8.7. Strategy Overview
      • 22.3.8.7.1. Marketing Strategy
      • 22.3.8.7.2. Product Strategy
      • 22.3.8.7.3. Channel Strategy
  • 22.3.9. Terumo Corporation
    • 22.3.9.1. Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Sales Footprint
    • 22.3.9.4. Key Financials
    • 22.3.9.5. SWOT Analysis
    • 22.3.9.6. Key Developments
    • 22.3.9.7. Strategy Overview
      • 22.3.9.7.1. Marketing Strategy
      • 22.3.9.7.2. Product Strategy
      • 22.3.9.7.3. Channel Strategy
  • 22.3.10. W. L. Gore & Associates Inc.
    • 22.3.10.1. Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Sales Footprint
    • 22.3.10.4. Key Financials
    • 22.3.10.5. SWOT Analysis
    • 22.3.10.6. Key Developments
    • 22.3.10.7. Strategy Overview
      • 22.3.10.7.1. Marketing Strategy
      • 22.3.10.7.2. Product Strategy
      • 22.3.10.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology